{"id":"1b7ef3fe-4908-5d84-84c4-95a95f3b9b13","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-the-pair-binds-better-than-either","predicate":"amplifies","statement":"A new GABA-B receptor subtype GABA-B R2 does not bind available GABA-B antagonists with measurable potency, GABA-B R1a, R1b and R2 alone do not activate Kir3-type potassium channels efficiently but co-expression yields a robust coupling to activation of Kir3 channels, there is evidence for assembly of heteromeric GABA-B receptors in vivo with the proteins immunoprecipitating and localizing together at dendritic spines, and the heteromeric receptor complexes exhibit a significant increase in agonist- and partial-agonist-binding potencies as compared with individual receptors and probably represent the predominant native GABA-B receptor.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"4401cd57-36c7-53e1-a87e-d07e57e3f7fa","mechanism_event_label":"Put the two subunits together and the receptor not only works but binds its agonist far better than either part did.","subject":{"id":"b0d8f9af-f1db-5b1b-a53d-8594105e621d","slug":"gabbr2","display_name":"GABA-B receptor subunit 2 / GABBR2","entity_type_key":"protein"},"object":{"id":"04325053-2ab3-5176-aaa1-0316f31e67b7","slug":"gabbr1","display_name":"GABA-B receptor subunit 1 / GABBR1","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"4401cd57-36c7-53e1-a87e-d07e57e3f7fa","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-the-pair-binds-better-than-either-event","event_type":"biochemical_relationship","label":"Put the two subunits together and the receptor not only works but binds its agonist far better than either part did.","description":"A new GABA-B receptor subtype GABA-B R2 does not bind available GABA-B antagonists with measurable potency, GABA-B R1a, R1b and R2 alone do not activate Kir3-type potassium channels efficiently but co-expression yields a robust coupling to activation of Kir3 channels, there is evidence for assembly of heteromeric GABA-B receptors in vivo with the proteins immunoprecipitating and localizing together at dendritic spines, and the heteromeric receptor complexes exhibit a significant increase in agonist- and partial-agonist-binding potencies as compared with individual receptors and probably represent the predominant native GABA-B receptor.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"2c706742-2e97-501d-ae17-067798d5eee0","slug":"gabab-heterodimer","display_name":"The GABA-B receptor heterodimer","entity_type_key":"protein_complex"},"role":"formed_complex","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"c414553f-549c-5c66-8557-9630edbafbf1","slug":"girk-channels","display_name":"G-protein-gated inwardly rectifying potassium (GIRK) channels","entity_type_key":"protein_family"},"role":"coupled_channel","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"b0d8f9af-f1db-5b1b-a53d-8594105e621d","slug":"gabbr2","display_name":"GABA-B receptor subunit 2 / GABBR2","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"04325053-2ab3-5176-aaa1-0316f31e67b7","slug":"gabbr1","display_name":"GABA-B receptor subunit 1 / GABBR1","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/gaba-research/9872317.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb\", \"start_char\": 0, \"end_char\": 1620, \"text_sha256\": \"6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Cloning of a second GABA-B subtype with binding potency and Kir3 channel coupling","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"GABA-B R1a, R1b and R2 expressed alone and in combination","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A companion study reaching the same conclusion by a different route, including colocalisation at dendritic spines in vivo.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.","comparator":null,"unit":null,"notes":"","entity":{"slug":"gaba","display_name":"Gamma-aminobutyric acid","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Put the two subunits together and the receptor not only works but binds its agonist far better than either part did.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[gb-p9872317] GABA(B)-receptor subtypes assemble into functional heteromeric complexes. (1998). https://pubmed.ncbi.nlm.nih.gov/9872317/ DOI: 10.1038/25360","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Transfected cells and dendritic spines","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"3ea40542-d4f9-5ec9-905f-12be265b8db6","evidence_kind":"source_excerpt","locator":"Lines 287-298","start_line":287,"end_line":298,"excerpt":"### gb-the-pair-binds-better-than-either\nA new GABA-B receptor subtype GABA-B R2 does not bind available GABA-B antagonists with measurable potency, GABA-B R1a, R1b and R2 alone do not activate Kir3-type potassium channels efficiently but co-expression yields a robust coupling to activation of Kir3 channels, there is evidence for assembly of heteromeric GABA-B receptors in vivo with the proteins immunoprecipitating and localizing together at dendritic spines, and the heteromeric receptor complexes exhibit a significant increase in agonist- and partial-agonist-binding potencies as compared with individual receptors and probably represent the predominant native GABA-B receptor.\nCondition category: normal\nnutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.\nplain_language: Put the two subunits together and the receptor not only works but binds its agonist far better than either part did.\norganism: Rat\ntissue_or_cell_type: Transfected cells and dendritic spines\nexperimental_model: Cloning of a second GABA-B subtype with binding potency and Kir3 channel coupling\nlimitations: A companion study reaching the same conclusion by a different route, including colocalisation at dendritic spines in vivo.\nexposure: GABA-B R1a, R1b and R2 expressed alone and in combination\nevidence_span: {\"source_cache\": \"artifacts/gaba-research/9872317.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb\", \"start_char\": 0, \"end_char\": 1620, \"text_sha256\": \"6a3eefc95d36d31151d094326c5d7f6dedd19b335dee29442de15b4b37ad9cfb\"}\n[gb-p9872317] GABA(B)-receptor subtypes assemble into functional heteromeric complexes. (1998). https://pubmed.ncbi.nlm.nih.gov/9872317/ DOI: 10.1038/25360","model_system":"Cloning of a second GABA-B subtype with binding potency and Kir3 channel coupling","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [gb-p9872317] GABA(B)-receptor subtypes assemble into functional heteromeric complexes. (1998). https://pubmed.ncbi.nlm.nih.gov/9872317/ DOI: 10.1038/25360","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"197c25bb-45fa-5e97-b3ab-2d2eff4e0d0a","stable_key":"import-1b599eb7-b22a-5fda-bcf0-9d92b5ae1311","title":"GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"07e36027ff70dbbe5563cddfa4758fd9b9b6eec148faecccafd476900b770456","revision_id":"a12d61de-f189-5bda-af3d-f31a1e61bccf","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}